Skip to main content
. 2020 Sep 14;20:878. doi: 10.1186/s12885-020-07343-w

Table 1.

Associations between angiopoietin-like 4 (ANGPTL4) expression and clinicopathologic factors of 161 patients with TNBC

Characteristics ANGPTL4 expression (cases) P value
Weak High
Total 66 95
Age (years)
  ≤ 40 9 (13.6%) 20 (21.1%) 0.228
  > 40 57 (86.4%) 75 (78.9%)
Family history of cancer 0.600
 No 52 (78.8%) 78 (82.1%)
 Yes 14 (21.2%) 17 (17.9%)
Menopause 0.435
 No 32 (51.5%) 52 (45.3%)
 Yes 34 (48.5%) 43 (54.7%)
History of other neoplasms 0.601
 No 63 (95.5%) 92 (96.8%)
 Yes 3 (4.5%) 3 (3.2%)
Stage 0.265
 0/ I/ II 44 (66.7%) 71 (74.7%)
 III 22 (33.3%) 24 (25.3%)
T status 0.395
 Tis/ T1/ T2 55 (83.3%) 74 (77.9%)
 T3/ T4 11 (16.7%) 21 (22.1%)
Lymph node metastasis 0.139
 N0 29 (43.9%) 53 (55.8%)
 N1–3 37 (56.1%) 42 (44.2%)
Histological differentiation 0.087
 1/ 2 24 (50.0%) 26 (38.6%)
 3 21 (50.0%) 44 (61.4%)
Vascular invasion
 No 47 (71.2%) 80 (84.2%) 0.047
 Yes 19 (28.8%) 15 (15.8%)
Disease recurrence
 No 39 (59.1%) 75 (78.9%) 0.006
 Yes 27 (40.9%) 20 (21.1%)
Progression 0.333
 Local recurrence 16 (59.3%) 9 (45.0%)
 Distant metastasis 11 (40.7%) 11 (55.0%)